Lexaria Bioscience Corp (LEXX)

[damAcon1]

...but exclusivity in North America is HUGE when their biggest competitor also happens to be "researching" the same technology.

"Altria's revenue, excluding excise taxes, dipped 1% in 2019. Its adjusted shipments of cigarettes, which exclude trade inventory movements and other factors, fell 7% due to the overall industry's decline and retail share losses to rival brands.

Its total share of the domestic retail cigarette market dipped from 50.2% in 2018 to 49.7% in 2019, as Marlboro, its premium brands, and discount brands all posted year-over-year declines. That pressure indicates that Altria's biggest domestic rival, British American Tobacco's (NYSE:BTI) Reynolds American, is gaining ground with U.S. smokers."

https://www.fool.com/investing/2020/10/05/is-altria-stock-a-buy/